Related references
Note: Only part of the references are listed.Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα):: results from a prospective study
K Lieb et al.
EUROPEAN PSYCHIATRY (2006)
Central nervous system changes in hepatitis C virus infection
Daniel M. Forton et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study
A Reichenberg et al.
AIDS (2005)
Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial
RJ Fontana et al.
JOURNAL OF HEPATOLOGY (2005)
Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors
MP McAndrews et al.
HEPATOLOGY (2005)
Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C
RC Hilsabeck et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2005)
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
CL Raison et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
MR Kraus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
MR Kraus et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Neuropsychological impairment in patients with chronic hepatitis C
RC Hilsabeck et al.
HEPATOLOGY (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review
E Dieperink et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
